Trials / Completed
CompletedNCT01902680
Phase II Study of Feasibility of Focal Therapy for Prostate Cancer of Good Prognosis With Permanent I125 Localized Implant.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Institut Claudius Regaud · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot prospective biomedical study of interventional type which includes 17 patients on 24 months (12 months of inclusion and 12 months of follow-up). The objective of this study is to verify that the focal therapy technique used (with the help of Koelis® system) allows to obtain optimal dosimetric coverage of the prostate target (ie dose of 160 Gy +-5% delivered on the envelope isodose) evaluated by CT scan performed 30 days after implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Focal brachytherapy | Focal brachytherapy with permanent I125 localized implant. |
Timeline
- Start date
- 2013-08-23
- Primary completion
- 2016-07-07
- Completion
- 2017-06-06
- First posted
- 2013-07-18
- Last updated
- 2026-04-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01902680. Inclusion in this directory is not an endorsement.